Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis

E-ISSN： 1875-533x|22|16|1943-1955

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.16, 2015-05, pp. : 1943-1955

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic Sclerosis at the Cellular Level: Molecular Pathways of Pathogenesis and its Implication on Future Drug Design

Current Medicinal Chemistry, Vol. 16, Iss. 30, 2009-10 ,pp. : 3986-3995

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1457-1464

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Molecular Targets for Treatment of Erectile Dysfunction: Vascular and Regenerative Therapies on the Horizon

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 427-441

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-11 ,pp. : 4059-4073

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Biologic Therapies in the Treatment of Rheumatoid Arthritis

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 542-548

Bentham Science Publishers

Access to resources Recommend Favorite